The patent covers a series of protocols that enable a device to be used as a biometric identity document, which can be ...
The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback